PSA: The Pharmaceutical Strategy and Alliances Conference 2017

Topics

• Right-Sizing R&D for Optimum Productivity: What Drives Growth?
• The 21st Century Big Pharma: How Much Should Industry`s Larger Players be Investing in R&D?
• After the Acquisition: Can Big Biotechs Thrive as Research Hubs Inside Big Pharma?
• Improve R&D Productivity through Better Decision-Making
• Market Access Panel: New Payment Mechanisms for Breakthrough Medicines
• The Opportunities — And Risks — For Pharma in Digital Health
• Investor Panel: Crossover Investors at the Crossroad — A Look at Valuations, the State of Biotech Exits, and Exit Strategies
• Commercial Panel: Innovating in "Mature" Markets and Finding Your Niche
• Making Sure the Drug Price is Right
• Business Development Panel: Checkpoint, Please! Dealmaking Intensifies in Oncology
• Taking Stock of Development Incentives: QIDP and Breakthrough Designation
• Biosimilars are Here. Now What?

Who should Attend

Senior attendees from the pharmaceuticals industry.